ArticleJournal of endocrinological investigation2019
The efficacy of HRAS and CDK4/6 inhibitors in anaplastic thyroid cancer cell lines.
S Lopes-Ventura et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
16 papers cite it
this papercites it